PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX
Portfolio Pulse from
Kahn Swick & Foti, LLC has issued a reminder for investors with losses over $100,000 in Pacira BioSciences, Inc. to file lead plaintiff applications by March 14, 2025, in a class action lawsuit. The lawsuit pertains to securities purchased between August 2, 2023, and August 8, 2024.
February 28, 2025 | 3:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pacira BioSciences faces a class action lawsuit with a lead plaintiff deadline of March 14, 2025, for investors with significant losses. This legal action could impact the company's stock price.
The class action lawsuit against Pacira BioSciences is significant due to the potential financial implications and investor sentiment. Legal challenges often lead to stock price volatility, especially if the lawsuit involves substantial investor losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100